Clinical Pathways Search Results

The suspected atopic dermatitis pathway highlights the care necessary in treating children with atopic dermatitis for all settings.

The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.

This pathway guides care of patients in the Emergency Department and inpatient units coming to the General Operating Rooms and radiologic procedures under Anesthesia/sedation.

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.

Guides medical, environmental and ongoing management for children with venous blood lead levels ≥ 3.5 μg/dL.

This pathway guides clinicians in laboratory studies and appropriate consultation to Bone Health team as needed, with a goal to prevent any fractures from occurring while children are in the hospital.

The post-hemorrhagic hydrocephalus clinical pathway aids clinicians in diagnosing and treating hydrocephalus after intraventricular hemorrhage (IVH) in preterm infants.

This pathway provides guidance for the care of all patients who have sustained a traumatic injury with risk to life or limb. Patients with recognized life threatening injuries are classified as Trauma Level One or Trauma Level Two and require initial evaluation and resuscitation in the Trauma Bay.

This pathway is intended for Emergency Department patients requiring procedural sedation who are healthy or those with mild systemic disease that is well controlled.

This pathway should be used to guide the health screening, evaluation and management of patients presenting with concerns for the mpox virus.